In our next step, we summarized the clinicopathological characteristics of the 30 patients in the first cohort, and tumour sizes were larger in patients with high ATP13A2 expression than in those with low ATP13A2 expression (Table 1). This evidence concerns the gene ATP13A2 and neoplasm.